Cerus Corp

Research Cerus Corp (CERS) on Bullrun: market cap USD 599.10M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCERS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 599.10M
• Financial periodFY2025
• RevenueUSD 233.80M
• Revenue growth16.1%
• Net income-USD 15.63M
• Free cash flowUSD 1.11M

Valuation Snapshot

latest market cap is USD 599.10M.

About Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Frequently asked questions

What is Cerus Corp's market cap?

Cerus Corp's market capitalization is USD 599.10M.

What does Cerus Corp do?

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.